Advion is the scientific leader in micro-fluidics systems. The company's scientific knowledge base creates unique nanotechnologies delivering speed, flexibility, and exceptional data quality. Advion is the micro-fluidics supplier of choice for customers demanding scientific excellence that provides better synthesis, accurate mass analysis, higher yields and greater throughput.
PICOSCRIPT is a privately owned company in the emergent Houston Medical Center. The company started in 2000, conducting experiments directed at creating a highly efficient and robust manufacturing process for building synthetic genes. The result of Picoscript's determined research is GENEBUILDER®, a fully automated and novel gene synthesis platform. GENEBUILDER combines patent pending and proprietary solutions, ingenious software, and a broad molecular and chemical expertise. The process allows Picoscript to provide completely accurate custom genes - any length genes, and any number of variations. All of this is offered at affordable prices, within a short two-week window. Picoscript's system is capable of producing even genome scale projects, creating new opportunities for research. During its core development, Picoscript formed beneficial alliances with a few international pharmaceutical and biotechnology companies, assisting with sequence and vector development. We experimented with various new methods and materials that could be used in building difficult-to-obtain genes or variations of genes. Picoscript has constructed and sequenced thousands of genes without failure. We excel due to our focus on service backed by a highly experienced team of biochemists, molecular biologists, protein crystallographers, and computer programmers.
GeneTech Biosciences (GeneTech) is a privately held biotechnology company located in Tempe, Arizona. GeneTech focuses on the development of products and technologies which enable the scientific community to rapidly develop the knowledge gained toward therapeutic and diagnostic products. Based on its cutting technology, GeneTech has been providing DNA synthesis services and gene construction services to the research community. The quality of oligonucleotide and other molecular biology services provided by GeneTech have been scrutinized by its peers in the research community. Research and Development are a crucial part of GeneTech's effort to improve our products and expand our services. Mission: GeneTech will be on the forefront of technology in gene discovery, synthesis, and analysis. We will provide partners in the research field with services to define new gene and generate new drugs. We will continue to develop the DNA technology for our partners to enhance their own research programs and expertise. Management: The scientific and entrepreneurial team offers experience in managing research projects as well as drug development programs.
Genaxis Biotechnology is a recently formed international company, dedicating its resources to the molecular biology and genetics area. By specializing in this field, Genaxis Biotechnology is able to supply your laboratory with all the reagents and instruments used on a regular basis, optimizing currently used techniques and developing new products keeping up with the latest developments in the field. Genaxis Biotechnology aims to provide you with all the products for your laboratory in the most cost effective way with a personalized service. Our personnel are highly qualified, there to listen to your comments and suggestions and to assist you in the application of our products.
http://www.creativebiolabs.com
Creative BioLabs [CD Inc] offers the most cost-effective custom protein expression services that cover gene synthesis, vector construction, expression optimization, fermentation and protein purification. Creative Biolabs has unparalleled capacity in delivering custom proteins in both small research and large preparative scale. Our GMP fermentation laboratories are equipped with 3.7-30 liter fermentors and Bioreactors that enable us to express protein in large scale. We produce recombinant proteins according to customer specifications or by developing customized protocols in house. Our customers can choose to enter into the protein expression pipeline at any stage depending on their needs.
ChemContract is the premier provider of custom synthesis and contract R&D services to the pharmaceutical, biotech and Agrochemical industries in India and world-wide. It is also a high quality supplier of Chemical Products like Speciality and Fine Chemicals(Pyridine,Piperidine, Piperazine, Thiophene), Chiral Building Blocks (Chiral Pryrrolidine, Furan , Piperidine alchohols,Amine derivatives) and Pharmaceutical Intermidiates at competitive prices. ChemContract has entered into strategic alliance with several top chemical companies in India which specializes in custom synthesis and bulk manufacturing of broad range of speciality chemicals, dyes, bulk drugs & pharmaceutical intermediates. With more than 60 R&D and manufacturing facilities spread across India, ChemContract offers a wide range of services and products used in chemical industries world-wide at a guaranteed unbeatable price. ChemContract provides an efficient, low cost, and productive way of doing research and development at par with world class research standard. ChemContract offers customizable resources for organic synthesis, process research & development, combinatorial synthesis, cGMP synthesis, analytical services & medicinal chemistry. It has full service capabilities from prototype development to world-wide distribution. Our reputation is built upon earning our customer's trust, respecting their need for confidentiality, and delivering on our promises. With more than 500 experienced scientists and several support personnel, ChemContract operates at the forefront of chemical technology.
Glen Research specializes in the supply of DNA synthesis reagents and RNA synthesis reagents. The company offers the widest range of phosphoramidites and solid supports for the chemical synthesis, modification, labelling, and purification of RNA and DNA oligonucleotides. We don't make oligos - Our customers do!
Link Technologies is committed to the training and development of staff at all levels. In this way we create and maintain a dynamic working environment in which our staff are rewarded whilst aspiring to higher personal standards. By achieving this we have the people to provide a tailored service to our customers of the highest quality. In February 1997, we decided to introduce the Investors In People programme as a means of staff development within the overall business strategy. The final assessment and award took place in March 1998. We were re-accredited to the standard in May 2001, then again in May 2004, and most recently in April 2007.
Otava provides the synthesis of compounds within a particular class of molecules selected by the customer. We have a chemical synthesis expertise in a wide range of drug discovery fields and can offer the production of compounds with exclusive or non-exclusive agreements (up to 100 grams). We also offer derivatization of various heterocyclic compounds, pharmacophores and small molecules.
Blue Heron Biotechnology has been a pioneer and leader of the gene synthesis market since its founding in 1999. Blue Heron provides the broadest range of synthetic DNA sequences and related services to thousands of researchers across multiple industries, including 19 of the top 20 pharmaceutical and biotechnology companies. With its proprietary GeneMaker® technology, Blue Heron regularly produces perfect DNA sequences from the simplest to the most complex structures and from 60 base pairs to well over 20,000 base pairs in length including the first synthetic DNA fragment over 50,000 base pairs. Unlike other company's approaches which rely on adaptations of standard PCR, Blue Heron's GeneMaker® platform includes proprietary design software which considers multiple characteristic of each section of the target DNA sequence and optimally builds each section using multiple, proprietary process technologies. This way, Blue Heron successfully completes projects where other company's standard processes have failed. Researchers from the leading pharmaceutical and biotechnology companies as well as emerging synthetic biology, BioFuels, and "clean tech" companies choose Blue Heron for their unmatched technological capability, quality of customer service, and long record of success and industry leadership. The demand for perfect DNA sequences is growing geometrically and research projects are becoming much more complex. Blue Heron has the experience and technological capability to meet this demand today and into the future.
JPT Peptide Technologies is an integrated provider of peptides, innovative peptide based tools and services for biomolecular research. Our well established peptide synthesis service guarantees the economical production of peptide libraries (Macro-Scale Peptide Sets) and specialty peptides according to our customers needs. JPT's production processes apply state of the art synthesizers and technologies. Our patented SPOT technology gives you a cost efficient access to tens-of-thousands of individual peptides (Micro-Scale Peptide Sets) within few weeks. JPT Peptide Technologies is the leading supplier and reliable partner for your protein and peptide synthesis.
Novacta Biosystems is a biotechnology company with a proprietary technology platform that harnesses the specificity and efficiency of biological systems, including biosynthetic pathway engineering, biotransformations and metabolite factories, in drug discovery and commercial applications in the chemicals industry. Novacta Biosystems delivers innovative products and services into the healthcare, food, cosmetic and chemical industries. Through the utilisation of leading edge technology and many years of experience in the pharmaceutical and biotechnology industry, Novacta has been able to meet the commercial requirements of several clients and partners while continuing to develop internal products.
Advion BioSciences, Inc. was founded in 1993 based on the novel techniques developed within the Cornell University laboratory of Dr. Jack Henion, a leading researcher in the field of Liquid Chromatography/Mass Spectrometry (LC/MS). The company's vision was to become a leading provider of bioanalytical contract services to the pharmaceutical industry. Pioneers within the industry, Advion quickly grew and currently employs over 150 professionals in two business divisions offering a variety of analytical services and products. With sales and support offices in North America, Europe, and Japan, Advion is a global company with customers in all of the top pharmaceutical companies, government life science research agencies and universities. Advion continues to expand its diverse portfolio of bioanalytical services and is a leading developer of innovative microfluidic chemistry products for the life science industry.
Activotec is a peptide synthesis Company providing innovative custom peptide synthesis services, peptide synthesizers and chemicals for chemical research and development. Our mission is to establish Activotec as the partner of choice for peptide-based drug discovery. The Company was formed in December 2002 as a spinout from the University of Southampton, with the support of Southampton University's Enterprise Office, the CEI, and benefiting from its partnership with IP Group. Activotec's core focus is customer service whether it's instrument development and support, delivery of quality custom synthesis services or chemicals, all critical to the success of your science. Our stock of instrument parts, consumables and chemicals offers a first class commitment to customer support. Activotec offers scientists a single point of expertise and assistance in research, design, manufacture of new, innovative and practical solutions.
ASINEX offers wide-ranging opportunities for collaboration in all relevant research fields: custom library synthesis, hit-to-lead projects, lead optimization and exclusive library synthesis. ASINEX chemistry know-how has truly evolved from every-day combinatorial approaches. We apply our medicinal chemistry expertise and proprietary techniques in organic synthesis to service-based chemistry projects. ASINEX has developed a trustworthy reputation as a provider of outsourcing since the completion of our first project more than 7 years ago. A special advantage of ASINEX is an impressive in-house library of building blocks which are particularly useful for optimizing various parameters of lead compounds or for generating diversity orientated or target-specific libraries. Along with "easy" chemical reactions (i.e. amide coupling, sulfonamide formation reductive amination) which are commonly used for the preparation of large compound libraries, ASINEX chemists are willing to explore a variety of modern synthetic techniques (e.g. boronic acid coupling, phenol and sulphonamide arylation, epoxide opening, C-C coupling reactions, multicomponent reactions, nucleophilic aromatic substitution, cycloaddition, cyclisations and heterocycle formations protection-deprotection sequence etc.) We are able to perform both solution phase and solid phase synthetic methodologies. ASINEX has a trustworthy reputation as a provider of chemistry services. Please review our references.
Alchemia Limited is a biotechnology company. The Company is engaged in developing new human therapeutics based on its drug discovery, dry targeting and synthesis technologies. Alchemia Limited and its subsidiaries’ operations are related to the research and development of new human pharmaceuticals. (Source: ARS)
GlycoDesign is currently developing ATH in preclinical studies as a therapeutic for the prevention of neurocognitive deficits during cardiopulmonary bypass surgery. The Company plans to partner with device companies to develop ATH as an antithrombotic coating on catheters used for dialysis as well as other indwelling medical devices where thrombosis is a serious clinical problem.
NimbleGen serves clients worldwide in life sciences, pharmaceuticals, biotechnology, academic research, industrial research, and bio-defense for government agencies. The firm employs about 65 people in its Madison headquarters and has operations in both Iceland and Germany. Baird Venture Partners and Venture Investors of Chicago; Cargill Ventures of Minneapolis, Skyline Ventures of Palo Alto, California; Tactics II Investments LLC of Northbrook, Illinois; the State of Wisconsin Investment Board and the Wisconsin Alumni Research Foundation participated in this latest financial round.
deCODE genetics, Inc. (deCODE) is a biopharmaceutical company applying its discoveries in human genetics to develop drugs and diagnostics for common diseases. The Company’s population approach and resources enable the Company to isolate genes and drug targets directly involved in the development of the diseases posing challenges to public health. deCODE is turning these discoveries into a growing pipeline of diagnostic tests and therapeutics taking aim at the causes of disease, not just the signs and symptoms. deCODE also offers its consumer genetic analysis service deCODEme. deCODEme enables individual subscribers to have their genome analyzed with approximately one million single-letter markers (SNPs), and to view, on their own secure personal Web interface, whether they carry genetic variants linked by the Company and others to risk of a growing list of common diseases, and to see what their genome can tell them about their ancestry and a number of other non-medical traits. (Source: 10-K)
Helix BioMedix, Inc. is a biopharmaceutical company with a library of structurally bioactive peptides and patents covering hundreds of thousands of peptide sequences. The Company has developed short, small-chain peptides with anti-infective, anti-inflammatory properties, such as the stimulation of cell proliferation and migration. These peptides are targeted for use as ingredients in cosmetics and topical therapeutics. The applications include anti-aging skin care, acne treatment, wound healing and the treatment of fungal dermatoses. It has developed numerous peptide sequences in the two areas of application, which includes consumer (skin care) and pharmaceutical. The Company has developed a number of peptides capable of stimulating certain aspects of the skin’s innate ability to regenerate and is marketing these peptides as ingredients for cosmetic use. (Source: 10-K)
Privacy Policy | Terms and Conditions | Do Not Sell My Personal Information | Websites Directory
Copyright © 2022 kwtbox.com. All Rights Reserved. US Business Directory